Alivus Life Sciences informs about press release

23 Jan 2025 Evaluate

Pursuant to regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), 2015, Alivus Life Sciences has informed that it enclosed the Press Release on the Unaudited Financial Results of the Company for the Third Quarter and Nine Months ended December 31, 2024.

The above information is a part of company’s filings submitted to BSE.

Alivus Life Sciences Share Price

1099.50 32.70 (3.07%)
28-Mar-2025 10:04 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1735.45
Dr. Reddys Lab 1144.05
Cipla 1441.70
Lupin 2026.50
Zydus Lifesciences 885.70
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...